Discover how AbbVie investors that bought the anxiety over the loss of Humira exclusivity are sitting on massive gains. Read ...

Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, ...

Analyst David Hynes of Canaccord Genuity maintained a Buy rating on Monday.com (MNDY – Research Report), boosting the price target to ...

Cheniere Energy is a top investment choice with its strong growth potential, global demand for LNG, and commitment to ...

List today: Grupo Financiero Galicia S.A. GGAL: This financial service holding company has seen the Zacks Consensus Estimate ...

Analyst Ryan MacDonald from Needham reiterated a Buy rating on Zeta Global Holdings Corp (ZETA – Research Report) and increased the price ...

Today’s episode of Full Court Finance at Zacks explores the stock market’s surge to fresh highs following the presidential ...

Looking ahead, Dutch Bros once again raised its full-year forecast. It is now guiding for revenue of between $1.255 billion ...

The Q3 earnings season for the tech giants has been a mixed bag. While some managed to impress investors with their ...

The overall value in Carnival stock is compelling here, making it more a buy than a sell or even a hold. This was an industry ...

The market focus, naturally, has been on FII selling this month. In the process, the street seems to have forgotten another ...

We’re now just days away from the ’24 elections, and what a race it’s been. Polls have been all over the place, and both ...